J&J | JNJ - مصاريف البيع والإدارة





مصاريف البيع والإدارة تغيير تاريخ
AbbVie USD 3.63B 54M 2026-06
Abbott USD 3.6B 330M 2026-06
Amgen USD 1.72B 134M 2026-06
AstraZeneca USD 5.8B 735M 2026-06
Baxter International USD 735M 7M 2026-06
Bayer EUR 3.96B 267M 2026-06
Becton, Dickinson and Co. USD 1.26B 48M 2026-06
Biogen USD 709.7M 155.4M 2026-06
Boston Scientific USD 1.8B 22M 2026-06
Bristol-Myers Squibb USD 1.83B 209M 2026-06
CONMED USD 145.55M 3.85M 2026-06
Cooper Companies USD 676.2M 303.1M 2026-03
Dexcom USD 358.7M 9M 2026-06
Edwards Lifesciences USD 561.2M 39M 2026-06
Eli Lilly USD 3.43B 496M 2026-06
Gilead Sciences USD 1.52B 70M 2026-06
GlaxoSmithKline GBP 2.19B 75M 2026-06
Globus Medical USD 286.82M 10.95M 2026-06
Insulet USD 344.8M 27.6M 2026-06
Integra LifeSciences USD 166.22M 12.01M 2026-06
Intuitive Surgical USD 617.9M 4.6M 2026-06
J&J USD 6.42B 381M 2026-06
Medtronic 2.96B 9M 2025-12
Merck USD 2.89B 219M 2026-06
Merit Medical Systems USD 129.23M 18.76M 2026-06
Novartis USD 3.24B 101M 2026-06
Pfizer USD 3.41B 496M 2026-06
Regeneron Pharmaceuticals USD 662.1M 14.4M 2026-06
Roche Holding CHF 6.37B 908M 2026-06
Sanofi EUR 2.63B 307M 2026-06
Stryker USD 2.12B 32M 2026-06
Tandem Diabetes Care USD 111.64M 3.45M 2026-06
Teva Pharmaceutical Industries USD 1.03B 34M 2026-06
Vertex Pharmaceuticals USD 582.2M 88.5M 2026-06
Zimmer Biomet Holdings USD 911.6M 61.7M 2026-06
Zoetis USD 592M 4M 2026-06